11/19/2024
8:48 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:50 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
8:30 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
8:30 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:53 PM | Point72 Asset Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024
4:50 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | Praxis Precision Medicines (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
|
11/14/2024
2:08 PM | Cormorant Asset Management, LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024
1:32 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
12:45 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:23 AM | Praxis Precision Medicines (Subject)
Verition Fund Management LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
12:29 PM | Capital Research Global Investors (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
11/12/2024
8:35 AM | Adage Capital Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/06/2024
6:59 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:57 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
10/15/2024
7:00 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:42 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
09/03/2024
7:15 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:20 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:22 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
8:00 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:01 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:02 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:03 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
8:31 PM | Praxis Precision Medicines (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
06/06/2024
5:55 PM | Norden Gregory (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:55 PM | Praxis Precision Medicines (Issuer)
YOUNG WILLIAM D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:55 PM | Cudkowicz Merit Ester (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:56 PM | Chodakewitz Jeffrey (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:56 PM | MITCHELL DEAN J (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:56 PM | DeSimone Jill (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:09 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
7:10 AM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:10 AM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
7:18 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
7:21 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
6:46 AM | Praxis Precision Medicines (Filer)
| Form DEF 14A | |
04/26/2024
6:47 AM | Praxis Precision Medicines (Filer)
| Form DEFA14A | |
03/29/2024
3:29 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
03/29/2024
3:30 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
When it comes to NVDA… “acceleration cycles” are the key (Ad) Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options…
By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)...
And thanks to many months and late nights working out the kinks of the systems…
They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! |
03/27/2024
3:49 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
03/26/2024
6:01 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
11:15 PM | Praxis Precision Medicines (Filer)
| Form EFFECT | |
03/05/2024
8:08 AM | Praxis Precision Medicines (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/05/2024
6:33 AM | Praxis Precision Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
6:12 AM | Praxis Precision Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
6:13 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:45 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
11:21 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/14/2024
7:55 AM | Praxis Precision Medicines (Subject)
Verition Fund Management LLC (Filed by)
| Form SC 13G | |
02/13/2024
6:08 PM | Avidity Partners Management LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/09/2024
4:21 PM | Blackstone Holdings I/II GP L.L.C. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/07/2024
6:46 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/06/2024
4:10 PM | KINGDON CAPITAL MANAGEMENT, L.L.C. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
02/05/2024
8:13 AM | Praxis Precision Medicines (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G/A | |
01/17/2024
3:47 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:48 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:49 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:51 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
4:20 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
01/12/2024
4:23 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
5:01 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
4:28 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
01/10/2024
3:10 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
8:08 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:09 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:10 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:11 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
4:19 PM | Praxis Precision Medicines (Filer)
| Form 424B5 | |
12/07/2023
4:23 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
3:33 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
3:30 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free PRAX Stock Alerts